Impact of Therapeutic Radioactive Iodine on the Recurrence of Papillary Thyroid Cancer With Extranodal Extension in Metastatic Lymph Nodes: A Propensity Score-matched Analysis

In PTC patients with ENE, mass size ≥4 cm, LN >5, or sTg ≥10 ng/mL had a benefit from RAI ≥100 mCi compared with RAI <100 mCi.

Authors

Jun‐Ho Choe (ORCID: https://orcid.org/0000-0001-6956-1840)
Jung Hwan Cho (ORCID: https://orcid.org/0000-0001-8578-2117)
Man Ki Chung (ORCID: https://orcid.org/0000-0002-1435-7786)
Jiyeon Hyeon (ORCID: https://orcid.org/0000-0003-3074-4142)
Nak Gyeong Ko (ORCID: https://orcid.org/0000-0002-4468-9589)
Boram Kim (ORCID: https://orcid.org/0000-0002-5125-8779)
Mi Hyeon Jin (ORCID: https://orcid.org/0000-0002-6436-2196)
Kyunga Kim (ORCID: https://orcid.org/0000-0002-0865-2236)
Sunghwan Suh (ORCID: https://orcid.org/0000-0001-6865-966X)
Joon Young Choi (ORCID: https://orcid.org/0000-0003-1060-0096)
Ji Cheol Bae (ORCID: https://orcid.org/0000-0002-4763-5797)
Ji Min Han (ORCID: https://orcid.org/0000-0002-7881-9732)
Sun Wook Kim (ORCID: https://orcid.org/0000-0002-6858-3439)
Hye In Kim
Jae Hoon Chung (ORCID: https://orcid.org/0000-0002-9563-5046)
Tae Hyuk Kim
Young Lyun Oh